Global Acute Heart Failure (AHF) Therapeutics Market Analysis 2013-2018 and Forecast 2019-2024

May 2019 | 84 pages | ID: G5D01CC96E3EN
99Strategy

Abstracts

SNAPSHOT

The global Acute Heart Failure (AHF) Therapeutics market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Acute Heart Failure (AHF) Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• B-Blockers
• Calcium Channel Blockers
• Cardiac Glycosides
• Diuretics
• Morphine
• Vasodilators/Nitrates
• Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Bayer AG
• Bristol-Myers Squibb Company
• Cardiorentis AG
• CVie Therapeutics Limited
• Cytokinetics, Inc.
• Merck & Co.
• Novartis AG
• Orion Corporation
• PhaseBio Pharmaceuticals, Inc

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Hospital
• Clinic
• Home Care

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
• Asia-Pacific (China, India, Japan, Southeast Asia etc.)
• South America (Brazil, Argentina etc.)
• Middle East & Africa (Saudi Arabia, South Africa etc.)

Contents

1 INDUSTRY OVERVIEW

1.1 Acute Heart Failure (AHF) Therapeutics Industry
  1.1.1 Overview
  1.1.2 Development of Acute Heart Failure (AHF) Therapeutics
1.2 Market Segment
  1.2.1 Upstream
  1.2.2 Downstream
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 ACUTE HEART FAILURE (AHF) THERAPEUTICS MARKET BY TYPE

3.1 By Type
  3.1.1 B-Blockers
  3.1.2 Calcium Channel Blockers
  3.1.3 Cardiac Glycosides
  3.1.4 Diuretics
  3.1.5 Morphine
  3.1.6 Vasodilators/Nitrates
  3.1.7 Others
3.2 Market Size
3.3 Market Forecast

4 MAJOR COMPANIES LIST

4.ACUTE HEART FAILURE (AHF) THERAPEUTICS BAYER AG (COMPANY PROFILE, SALES DATA ETC.)

4.2 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
4.3 Cardiorentis AG (Company Profile, Sales Data etc.)
4.4 CVie Therapeutics Limited (Company Profile, Sales Data etc.)
4.5 Cytokinetics, Inc. (Company Profile, Sales Data etc.)
4.6 Merck & Co. (Company Profile, Sales Data etc.)
4.7 Novartis AG (Company Profile, Sales Data etc.)
4.8 Orion Corporation (Company Profile, Sales Data etc.)
4.9 PhaseBio Pharmaceuticals, Inc (Company Profile, Sales Data etc.)

5 MARKET COMPETITION

5.1 Company Competition
5.2 Regional Market by Company

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Hospital
  6.1.2 Demand in Clinic
  6.1.3 Demand in Home Care
6.2 Regional Demand Comparison
6.3 Demand Forecast

7 REGION OPERATION

7.1 Regional Production
7.2 Regional Market
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
    7.3.1.2 by Country (U.S., Canada, Mexico)
  7.3.2 Europe
    7.3.2.1 Overview
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  7.3.4 South America
    7.3.4.1 Overview
    7.3.4.2 by Country (Brazil, Argentina etc.)
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel

9 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Upstream Segment of Acute Heart Failure (AHF) Therapeutics
Table Application Segment of Acute Heart Failure (AHF) Therapeutics
Table Global Acute Heart Failure (AHF) Therapeutics Market 2013-2024, by Application, in USD Million
Table Major Company List of B-Blockers
Table Major Company List of Calcium Channel Blockers
Table Major Company List of Cardiac Glycosides
Table Major Company List of Diuretics
Table Major Company List of Morphine
Table Major Company List of Vasodilators/Nitrates
Table Major Company List of Others
Table Global Acute Heart Failure (AHF) Therapeutics Market 2013-2018, by Type, in USD Million
Table Global Acute Heart Failure (AHF) Therapeutics Market 2013-2018, by Type, in Volume
Table Global Acute Heart Failure (AHF) Therapeutics Market Forecast 2019-2024, by Type, in USD Million
Table Global Acute Heart Failure (AHF) Therapeutics Market Forecast 2019-2024, by Type, in Volume
Table Bayer AG Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cardiorentis AG Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of Cardiorentis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CVie Therapeutics Limited Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of CVie Therapeutics Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cytokinetics, Inc. Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of Cytokinetics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Orion Corporation Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of Orion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PhaseBio Pharmaceuticals, Inc Overview List
Table Acute Heart Failure (AHF) Therapeutics Business Operation of PhaseBio Pharmaceuticals, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Acute Heart Failure (AHF) Therapeutics Sales Revenue 2013-2018, by Company, in USD Million
Table Global Acute Heart Failure (AHF) Therapeutics Sales Revenue Share, by Company, in USD Million
Table Global Acute Heart Failure (AHF) Therapeutics Sales Volume 2013-2018, by Company, in Volume
Table Global Acute Heart Failure (AHF) Therapeutics Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Acute Heart Failure (AHF) Therapeutics Demand Forecast 2019-2024, by Application, in USD Million
Table Acute Heart Failure (AHF) Therapeutics Demand Forecast 2019-2024, by Application, in Volume
Table Acute Heart Failure (AHF) Therapeutics Production 2013-2018, by Region, in USD Million
Table Acute Heart Failure (AHF) Therapeutics Production 2013-2018, by Region, in Volume
Table Global Acute Heart Failure (AHF) Therapeutics Market 2013-2018, by Region, in USD Million
Table Global Acute Heart Failure (AHF) Therapeutics Market Share 2013-2018, by Region, in USD Million
Table Global Acute Heart Failure (AHF) Therapeutics Market 2013-2018, by Region, in Volume
Table Global Acute Heart Failure (AHF) Therapeutics Market Share 2013-2018, by Region, in Volume
Table North America Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in USD Million
Table North America Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in Volume
Table Europe Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in USD Million
Table Europe Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in Volume
Table South America Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in USD Million
Table South America Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size 2013-2018, by Country, in Volume
Table Acute Heart Failure (AHF) Therapeutics Market Forecast 2019-2024, by Region, in USD Million
Table Acute Heart Failure (AHF) Therapeutics Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List

List Of Figures

LIST OF FIGURES

Figure Global Acute Heart Failure (AHF) Therapeutics Market Growth 2013-2018, by Type, in USD Million
Figure Global Acute Heart Failure (AHF) Therapeutics Market Growth 2013-2018, by Type, in Volume
Figure North America Acute Heart Failure (AHF) Therapeutics Market Concentration, in 2018
Figure Europe Acute Heart Failure (AHF) Therapeutics Market Market Concentration, in 2018
Figure Asia-Pacific Acute Heart Failure (AHF) Therapeutics MMarket Concentration, in 2018
Figure South America Acute Heart Failure (AHF) Therapeutics Market Concentration, in 2018
Figure Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Concentration, in 2018
Figure Acute Heart Failure (AHF) Therapeutics Demand in Hospital, 2013-2018, in USD Million
Figure Acute Heart Failure (AHF) Therapeutics Demand in Hospital, 2013-2018, in Volume
Figure Acute Heart Failure (AHF) Therapeutics Demand in Clinic, 2013-2018, in USD Million
Figure Acute Heart Failure (AHF) Therapeutics Demand in Clinic, 2013-2018, in Volume
Figure Acute Heart Failure (AHF) Therapeutics Demand in Home Care, 2013-2018, in USD Million
Figure Acute Heart Failure (AHF) Therapeutics Demand in Home Care, 2013-2018, in Volume
Figure North America Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in USD Million
Figure North America Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in Volume
Figure Europe Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in USD Million
Figure Europe Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in Volume
Figure South America Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in USD Million
Figure South America Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview